Atlas Trials

Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)

RecordFirmDate
Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NCT02179671)AstraZeneca2014-07-25
Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC (NCT01933932)AstraZeneca2013-09-25
Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment. (NCT01750281)AstraZeneca2012-12-18

Track Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) automatically

Every clearance here is in the API, with alerts when new ones post.